Can You Take Testosterone While Pregnant? No, It's Contraindicated
Testosterone cypionate is FDA Category X during pregnancy, risking irreversible virilization of a female fetus. Also contraindicated while breastfeeding.
78 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 60 of 78 clinical reviews.
Testosterone cypionate is FDA Category X during pregnancy, risking irreversible virilization of a female fetus. Also contraindicated while breastfeeding.
Aetna (CVS Health) covers testosterone cypionate for diagnosed male hypogonadism with prior authorization. Learn formulary tier, step therapy rules, PA criteria, appeal steps, and cost-saving strategies.
A clinical and insurance guide to Anthem (Elevance Health) coverage of testosterone cypionate, including prior authorization criteria, step therapy requirements, formulary tier, and how to appeal a denial.
A clinical and insurance guide on Blue Cross Blue Shield (Federated) coverage for testosterone cypionate, including prior authorization criteria, formulary tiers, step therapy requirements, and how to appeal a denial.
A clinical and practical guide to Cigna's coverage policies for testosterone cypionate, including prior authorization criteria, formulary tier, step therapy requirements, and how to appeal a denial.
Find out whether Humana covers testosterone cypionate for hypogonadism, including formulary tier, prior authorization requirements, step therapy rules, and how to appeal a denial.
A guide to Kaiser Permanente formulary status, prior authorization criteria, step therapy requirements, and appeal strategies for testosterone cypionate coverage.
Medicare Advantage plans generally cover testosterone cypionate for diagnosed male hypogonadism under Part D formularies, but prior authorization and step therapy requirements vary by carrier.
State Medicaid coverage for testosterone cypionate varies widely. Learn formulary tiers, prior authorization criteria, step therapy rules, and how to appeal a denial.
TRICARE covers testosterone cypionate for diagnosed male hypogonadism. Learn about formulary tier, prior authorization requirements, step therapy, appeal options, and out-of-pocket costs for military beneficiaries.
A detailed guide to UnitedHealthcare coverage for testosterone cypionate, including formulary tier, prior authorization criteria, step therapy requirements, and how to appeal a denial.
LiverTox and T-Trials data show injectable testosterone cypionate bypasses first-pass liver metabolism and showed no significant ALT/AST rise at standard doses.
Testosterone cypionate can improve mood and energy but may cause irritability at high doses. See T-Trials data, onset timing, and dosing guidance.
Testosterone cypionate can improve sleep at physiologic doses but raises apnea risk at high doses. See how dose and level affect your sleep.
Clinical guide to testosterone cypionate dosing in adolescents aged 12 to 17, covering delayed puberty, hypogonadism, and gender-affirming protocols with dose ranges, titration schedules, and safety monitoring.
A comprehensive clinical guide to testosterone cypionate safety in adolescents aged 12, 17, covering growth-plate risks, dosing protocols, mental-health monitoring, and FDA guidance.
A guide to testosterone cypionate use after bariatric surgery, covering hypogonadism prevalence, dosing, monitoring, and drug absorption changes post-operatively.
A clinical deep-dive into how testosterone cypionate affects autoimmune conditions, including immune modulation mechanisms, disease-specific considerations, monitoring protocols, and primary-literature evidence.
A deep dive into how testosterone cypionate affects memory, verbal fluency, spatial reasoning, and mood in hypogonadal men, citing T-Trials and primary literature.
A guide to how testosterone cypionate affects appetite, hunger hormones, food cravings, and caloric intake in men with hypogonadism, with primary-literature citations throughout.
How testosterone cypionate affects bone mineral density and fracture risk in men with hypogonadism, what the evidence actually shows, and a monitoring framework for prescribers and patients.
A clinical-depth review of testosterone cypionate and cancer risk signals, covering prostate cancer, breast cancer, erythrocytosis, and the current evidence from T-Trials, TRAVERSE, and major endocrine guidelines.
An evidence-based analysis of testosterone cypionate's long-term cardiovascular effects, covering hematocrit, lipids, blood pressure, and the TRAVERSE and T-Trials data.
See which FDA-approved manufacturers (Pfizer, Hikma) make testosterone cypionate, DEA quota limits, and the shortage history prescribers and patients should know.
Compare testosterone cypionate pricing, efficacy, and side-effect profiles against enanthate, undecanoate (Aveed), topical gels (AndroGel), patches, and oral jatenzo. Includes real-world cost data, trial evidence, and switching guidance.
Complete guide to testosterone cypionate dosing for adults aged 30 to 49, including starting doses, titration schedules, injection frequency, monitoring labs, and dose adjustments based on clinical guidelines and trial data.
What adults 50 to 64 should know about confirming hypogonadism, individualized testosterone cypionate dosing, mid-interval labs, hematocrit, prostate monitoring, and cardiovascular evidence.
Clinical guide to testosterone cypionate dosing in men aged 18-29, covering starting doses, titration, fertility preservation with hCG, and monitoring schedules backed by endocrine society guidelines.
A guide to testosterone cypionate dosing, mechanism of action, and clinical management when liver function is compromised. Includes trial data, FDA label guidance, and a practical dosing framework.
A clinician-level guide to testosterone cypionate dosing when kidney function is reduced, covering pharmacokinetics, monitoring, dose adjustment strategies, and evidence from primary sources.
Evidence-based guide to foods, supplements, and nutrients that interact with testosterone cypionate, including effects on absorption, metabolism, and clinical outcomes.
A guide to testosterone cypionate for male hypogonadism covering FDA approval, T-Trials evidence, dosing protocols, monitoring, side effects, and insurance coverage.
A guide to testosterone cypionate for secondary hypogonadism covering FDA approval status, T-Trials evidence, dosing protocols, fertility preservation, and monitoring benchmarks.
A clinical overview of next-generation testosterone cypionate delivery systems, novel formulations in development, and pipeline compounds that may reshape TRT protocols.
Evidence-based guide to testosterone cypionate dosing in men 65 and older, covering safe starting doses, monitoring protocols, cardiovascular considerations, and when to adjust or stop therapy.
Complete guide to monitoring testosterone cypionate therapy in men 65 and older, covering lab schedules, cardiovascular risk, falls risk, hematocrit targets, and deprescribing thresholds backed by the T-Trials and current endocrine guidelines.
A guide to hair and skin changes linked to testosterone cypionate therapy, including DHT-driven alopecia, acne, oily skin, and evidence-based management strategies.
Evidence-based safety guide for testosterone cypionate use in geriatric men (65+), covering cardiovascular risk, prostate screening, polypharmacy, falls, and monitoring protocols.
Evidence-based guide to testosterone cypionate use in special populations including organ transplant recipients, people living with HIV, opioid-induced hypogonadism, and chronic kidney disease. Dosing, monitoring, and safety data from primary sources.
A deep dive into testosterone cypionate microdosing protocols, covering pharmacokinetics, dose ranges, injection frequency, clinical trial data, and guideline recommendations for men with hypogonadism.
A guide to the testosterone cypionate missed-dose protocol, including timing rules, trough pharmacokinetics, and how testosterone cypionate works at the receptor level.
Evidence-based monitoring protocol for testosterone cypionate therapy in men aged 30, 49, including lab timing, hematocrit thresholds, cardiovascular screening, and fertility preservation.
A guide to testosterone cypionate monitoring protocols for men aged 50 to 64, covering lab timing, cardiovascular risk, hematocrit, prostate surveillance, and dose adjustment thresholds.
A complete clinical guide to testosterone cypionate monitoring for men aged 18 to 29, covering labs, dosing schedules, fertility preservation, and guideline-based safety thresholds.
A guide to monitoring testosterone cypionate therapy in adolescents aged 12, 17, covering lab panels, bone-age imaging, growth velocity, mental health tracking, and dosing milestones.
A complete guide to the testosterone cypionate monitoring schedule: which labs to order, when to order them, what targets to hit, and why each test matters for safe, effective TRT.
An evidence-based look at testosterone cypionate for muscle preservation in men with hypogonadism, covering dosing tradeoffs, resistance training, nutrition, and monitoring, with explicit notes on what is established versus what still needs verification.
A guide to testosterone cypionate off-label applications, from female sexual dysfunction to sarcopenia, with trial-level evidence ratings for each use.
A guide to testosterone cypionate overdose, accidental excess dosing, mechanism of action, and clinical management protocols with PubMed-cited evidence.
A clinical review of testosterone cypionate's patent history, generic availability, current formulations, and what prescribers and patients should know about access and cost in 2024 and beyond.
A complete clinical guide to monitoring testosterone cypionate therapy in children under age 12, covering FDA labeling, weight-based dosing, bone age surveillance, lab schedules, and safety endpoints.
Evidence-based review of testosterone cypionate safety in children under 12, including FDA labeling, weight-based dosing, bone age monitoring, and growth plate risks.
A deep dive into how genetic variants in AR, CYP19A1, SHBG, and CYP3A4/5 alter testosterone cypionate response, dosing, and side-effect risk, with trial citations and clinical decision guidance.
A deep dive into testosterone cypionate absorption, distribution, metabolism, and excretion, with PK data, dosing implications, and clinical trial evidence.
Why your testosterone cypionate therapy has stopped working, and what to do about it. MD-level guidance on diagnosing true non-response, adjusting protocols, and optimizing labs for men on TRT.
Evidence-based guide to holding testosterone cypionate before surgery: timing, thromboembolic risk, anesthesia interactions, lab monitoring, and restart protocols.
A clinical review of real-world evidence for testosterone cypionate from patient registries, observational cohorts, and post-marketing studies, with PubMed-cited data on outcomes, safety, and long-term effects.
A guide to the hormonal, sexual, mood, and metabolic rebound effects that occur after stopping testosterone cypionate, including timelines, clinical trial data, and recovery protocols.
A country-by-country breakdown of testosterone cypionate's prescription status, controlled-substance scheduling, and availability across the US, EU, Canada, and the UK.
A guide to testosterone cypionate safety in men and women aged 50 to 64, covering cardiovascular risks, hematologic effects, dosing, monitoring, and evidence from the T-Trials and beyond.
Showing the first 60 matches among the loaded articles. Use the page links below to browse the complete library.

LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.